3Koelewijn JM, Vfijkotte TG, Van der SchootCE, et al. Effect of screening for red cell antibodies, otherthan anti-D, to detect hemolytic disease of the fetusand newborn : a population study in the Netherlands [ J ]. Transfusion, 2008,48 ( 5 ) :941-952. 被引量：1
4Koelewijn JM, VrijkotteTG, DeHaasM, et al. Riskfactors for the presence ofnon-rhesusD red blood cellantibodies in pregnancy[ J]. BJOG,2009,116(5 ) :655 -664. 被引量：1
4JF Watchko. dentification of neonates at risk for hazardoushyperbiliru- binemia: emerging clinical insights [J]. Pediatr Clin North Am, 2009, 56(3 ):671-687. 被引量：1
5JM Koelewijin, TGM Vrijkotte, M De Haas, et al. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy [J]. Journal of Obstetrics, 2009, 116( 5 ):655-664. 被引量：1
7Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights[J]. Pediatr Clin North Am, 2009, 56(3): 671-687. 被引量：1
8Koelewijin JM, Vrijkotte TG, der Haas M, et al. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy[J]. BJOG, 2009, 116(5): 655-664. 被引量：1
